美股A股
StockGist
Back
10-K/A2026-04-30· deepseek-chat

SCWO · 374Water, Inc.

0001654954-26-004179

SEC filing

Summary

A transitional year marked by leadership changes and strategic financing, with no revenue reported and ongoing operating losses as the company invests in commercializing its AirSCWO technology.

Key takeaways

Full analysis

Leadership Transition and Strategic Reset

374Water underwent a significant leadership overhaul during and after FY2025. CEO Christian Gannon stepped down in October 2025, replaced by interim CEO Stephen Jones, who was succeeded by Daniel Bogar in February 2026. The CFO role also changed, with Russell Kline departing in March 2026 and Adrienne Anderson returning as interim CFO. The board was refreshed with new directors including James Pawloski (former Veolia executive), Charles Weiser (CPA), Bradley Freels (real estate), and Stephen McKnight, signaling a shift toward operational and financial expertise. These changes suggest the company is positioning for a more aggressive commercialization phase.

Pre-Revenue Stage and Investment in Technology

The company reported no revenue for FY2025, consistent with its pre-commercial stage. All efforts are focused on developing and deploying its supercritical water oxidation (AirSCWO) system for waste treatment. Operating expenses, including R&D and SG&A, consumed cash as the company built out its technology and sales infrastructure. The lack of revenue underscores the high-risk, high-reward nature of the investment, with success dependent on market adoption.

Financing and Cash Position

During FY2025, the company financed operations through equity and debt offerings. Management has not provided specific cash runway details, but the ongoing need for capital is evident given the pre-revenue stage. The company may require additional financing to support commercialization efforts.

Commercial Outlook and Risks

Management's outlook is qualitative, emphasizing the commercialization of the AirSCWO system. The appointment of James Pawloski, with his Veolia background, suggests a focus on partnerships and large-scale deployments. However, the company faces execution risks: technology scale-up, regulatory approvals, and customer adoption. The lack of revenue guidance and the need for additional financing create uncertainty. Investors should monitor pilot project announcements, partnership developments, and cash runway as key indicators of progress.